Vanguard Group Inc

13F Holdings History for Royalty Pharma plc - Common Stock (RPRX)

Symbol: RPRX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 10.9M shares
Security Ownership: 2.52%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Royalty Pharma plc Common Stock (RPRX)

2025-10-30 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.9M shares of Royalty Pharma plc Common Stock (RPRX). This represents 2.52% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	2.52%		$386M	10.9M			$35.28	13G/A	9/30/2025	30 Oct 2025 15:48:49

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	-0.01%	$386M	10.9M	-25,441,140	-69.9%	$35.28	Q3 2025
6/30/2025	0.02%	0%	$1.31B	36.4M	-299,770	-0.82%	$36.03	Q2 2025
3/31/2025	0.02%	0%	$1.14B	36.7M	-676,561		$31.13	Q1 2025
12/31/2024	0.02%	0%	$953M	37.4M	-231,114	-0.61%	$25.51	Q4 2024
9/30/2024	0.02%	0%	$1.06B	37.6M	-437,258	-1.15%	$28.29	Q3 2024
6/30/2024	0.02%	+0%	$1B	38M	+322,699	+0.86%	$26.37	Q2 2024
3/31/2024	0.02%	0%	$1.14B	37.7M	-297,840	-0.78%	$30.37	Q1 2024
12/31/2023	0.02%	0%	$1.07B	38M	-1,439,832	-3.65%	$28.09	Q4 2023
9/30/2023	0.03%	+0%	$1.07B	39.4M	+589,558	+1.52%	$27.14	Q3 2023
6/30/2023	0.03%	+0%	$1.19B	38.8M	+917,777	+2.42%	$30.74	Q2 2023
3/31/2023	0.03%	+0%	$1.37B	37.9M	+2,302,228	+6.46%	$36.03	Q1 2023
12/31/2022	0.04%	+0%	$1.41B	35.6M	+675,981	+1.93%	$39.52	Q4 2022
9/30/2022	0.04%	+0%	$1.4B	35M	+2,098,034	+6.39%	$40.18	Q3 2022
6/30/2022	0.04%	+0%	$1.38B	32.9M	+993,155	+3.12%	$42.04	Q2 2022
3/31/2022	0.03%	+0%	$1.24B	31.9M	+2,224,056	+7.5%	$38.96	Q1 2022
12/31/2021	0.03%	0%	$1.18B	29.6M	-391,497	-1.3%	$39.85	Q4 2021
9/30/2021	0.03%	+0.01%	$1.09B	30M	+5,685,862	+23.4%	$36.14	Q3 2021
6/30/2021	0.02%	+0%	$998M	24.3M	+1,829,607	+8.13%	$40.99	Q2 2021
3/31/2021	0.03%	+0.03%	$982M	22.5M	+20,673,627	+1124%	$43.62	Q1 2021
12/31/2020	0%	+0%	$92M	1.84M	+426,080	+30.2%	$50.05	Q4 2020
9/30/2020	0%	+0%	$59.4M	1.41M	+29,526	+2.13%	$42.07	Q3 2020
6/30/2020	0%	+0%	$67.2M	1.38M	+1,383,360	NEW	$48.55	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.